Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • DPHARM: Where to begin with AI in clinical trials?

DPHARM: Where to begin with AI in clinical trials?

September 18, 2026Posted inBiotechnology

The promise of AI to transform the clinical trial process is being realized in fits and starts, but early applications of the technology might be surprising.

Post navigation

Previous Post
Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope
Next Post
With pioneering ADHD data, Alkermes eyes orexin agonist as potential ‘company changer’

Recent Posts

  • Corrected Perfusate Keeps Donor Lungs Viable Through 12 Hours of Ex Vivo Perfusion in Pigs
  • Star-Spored Mushrooms in China Hide Three New Species and a Toxic Mystery
  • When Smoothing Makes Robots Jerkier: A Costly Lesson in Fine-Tuning Small Vision-Language-Action Models
  • US Medical Residencies Are Flying Blind on AI Training, National Survey Finds
  • AI Learns to Play the Accordion by Encoding Music Theory into a Knowledge Graph

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top